Last reviewed · How we verify
Voriconazole inhaled
At a glance
| Generic name | Voriconazole inhaled |
|---|---|
| Also known as | ZP-059 |
| Sponsor | Zambon SpA |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
- Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
- Factors on Therapeutic Drug Monitoring and Safety of Voriconazole in Critically Ill Elderly Patients
- An Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDM
- Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma (PHASE1)
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects (PHASE1)
- Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects (PHASE1)
- Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |